• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中的癌症干细胞及其与化疗耐药性的关联。

Cancer stem cells in colorectal cancer and the association with chemotherapy resistance.

机构信息

Department of Pathology, Guangdong Medical University, No.1 Xincheng Road, Dongguan, 523808, Guangdong Province, China.

School of Public Health, Guangdong Medical University, Dongguan, 523808, Guangdong Province, China.

出版信息

Med Oncol. 2021 Mar 18;38(4):43. doi: 10.1007/s12032-021-01488-9.

DOI:10.1007/s12032-021-01488-9
PMID:33738588
Abstract

The incidence and mortality of colorectal cancer (CRC) have always been among the highest in the world, although the diagnosis and treatment are becoming more and more advanced. At present, the main reason is that patients have acquired drug resistance after long-term conventional drug treatment. An increasing number of evidences confirm the existence of cancer stem cells (CSCs), which are a group of special cells in cancer, only a small part of cancer cells. These special cell populations are not eliminated by chemotherapeutic drugs and result in tumor recurrence and metastasis after drug treatment. CSCs have the ability of self-renewal and multidirectional differentiation, which is associated with the occurrence and development of cancer. CSCs can be screened and identified by related surface markers. In this paper, the characteristic surface markers of CSCs in CRC and the related mechanism of drug resistance will be discussed in detail. A better understanding of the mechanism of CSCs resistance to chemotherapy may lead to better targeted therapy.

摘要

结直肠癌(CRC)的发病率和死亡率一直位居世界前列,尽管其诊断和治疗方法越来越先进。目前,主要原因是患者在长期常规药物治疗后产生了耐药性。越来越多的证据证实了癌症干细胞(CSC)的存在,CSC 是癌症中一组特殊的细胞,仅占癌症细胞的一小部分。这些特殊的细胞群不会被化疗药物消除,导致药物治疗后肿瘤复发和转移。CSC 具有自我更新和多向分化的能力,与癌症的发生和发展有关。可以通过相关的表面标记物来筛选和鉴定 CSC。本文将详细讨论 CRC 中 CSC 的特征表面标记物及其相关耐药机制。更好地了解 CSC 对化疗的耐药机制可能会导致更好的靶向治疗。

相似文献

1
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance.结直肠癌中的癌症干细胞及其与化疗耐药性的关联。
Med Oncol. 2021 Mar 18;38(4):43. doi: 10.1007/s12032-021-01488-9.
2
Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.结直肠癌干细胞通过上调含F-Box/WD重复序列蛋白7并随后降解c-Myc获得化疗耐药性。
Stem Cells. 2017 Sep;35(9):2027-2036. doi: 10.1002/stem.2668. Epub 2017 Jul 31.
3
Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.PER3的过表达通过抑制Notch和β-连环蛋白信号通路来抑制结直肠癌干细胞样细胞的自我更新能力和化疗耐药性。
Oncol Res. 2017 May 24;25(5):709-719. doi: 10.3727/096504016X14772331883976. Epub 2016 Oct 26.
4
The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.癌症干细胞与结直肠癌耐药的关系
Cells. 2020 Jun 3;9(6):1392. doi: 10.3390/cells9061392.
5
Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.Lgr5与CXCR4的共表达是结直肠癌癌干细胞样细胞的特征。
Oncotarget. 2016 Dec 6;7(49):81144-81155. doi: 10.18632/oncotarget.13214.
6
Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.双重阻断PI3K和mTOR通过诱导分化提高对SW620人结肠直肠癌干细胞的化疗效果。
J Korean Med Sci. 2016 Mar;31(3):360-70. doi: 10.3346/jkms.2016.31.3.360. Epub 2016 Feb 17.
7
Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480.人结肠癌细胞系HCT116和SW480中癌症干细胞耐药性的特征分析
Biochem Biophys Res Commun. 2017 Aug 12;490(1):29-35. doi: 10.1016/j.bbrc.2017.05.176. Epub 2017 May 30.
8
[Research progression in colorectal cancer stem cells].[结直肠癌干细胞的研究进展]
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Mar;16(3):297-300.
9
MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.miR-148a 通过靶向 WNT10b 并调节顺铂耐药结直肠癌细胞中的 β-连环蛋白信号通路抑制细胞侵袭和迁移。
Biomed Pharmacother. 2019 Jan;109:902-909. doi: 10.1016/j.biopha.2018.10.080. Epub 2018 Nov 5.
10
Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.自噬有助于结直肠癌干细胞在奥沙利铂治疗下的富集和存活。
Cancer Lett. 2015 May 28;361(1):128-36. doi: 10.1016/j.canlet.2015.02.045. Epub 2015 Mar 5.

引用本文的文献

1
An Endolichenic Fungi-Derived Fatty Acid, cis-10-Nonadecenoic acid, Suppresses Colorectal Cancer Stemness.一种源自内生真菌的脂肪酸,顺式-10-十九碳烯酸,可抑制结直肠癌干性。
Biomol Ther (Seoul). 2025 Sep 1;33(5):842-851. doi: 10.4062/biomolther.2025.062. Epub 2025 Aug 6.
2
Dichloroacetate and Salinomycin as Therapeutic Agents in Cancer.二氯乙酸盐和沙利霉素作为癌症治疗药物
Med Sci (Basel). 2025 Apr 23;13(2):47. doi: 10.3390/medsci13020047.
3
Cancer stem cells and their role in metastasis.癌症干细胞及其在转移中的作用。

本文引用的文献

1
Stem cell quiescence and its clinical relevance.干细胞静止及其临床相关性。
World J Stem Cells. 2020 Nov 26;12(11):1307-1326. doi: 10.4252/wjsc.v12.i11.1307.
2
Molecular analysis of the massive GSH transport mechanism mediated by the human Multidrug Resistant Protein 1/ABCC1.人多药耐药蛋白 1/ABCC1 介导的巨大 GSH 转运机制的分子分析。
Sci Rep. 2020 May 6;10(1):7616. doi: 10.1038/s41598-020-64400-x.
3
Comprehensive review of targeted therapy for colorectal cancer.结直肠癌靶向治疗的综合综述。
Cent European J Urol. 2025;78(1):40-51. doi: 10.5173/ceju.2024.0144. Epub 2024 Nov 28.
4
Mapping the intellectual structure and emerging trends on nanomaterials in colorectal cancer: a bibliometric analysis from 2003 to 2024.绘制结直肠癌中纳米材料的知识结构和新兴趋势:2003年至2024年的文献计量分析
Front Oncol. 2025 Jan 8;14:1514581. doi: 10.3389/fonc.2024.1514581. eCollection 2024.
5
Serum EphA2 as a Promising Biomarker for the Early Detection and Diagnosis of Colorectal Cancer.血清EphA2作为结直肠癌早期检测和诊断的一种有前景的生物标志物。
Biomolecules. 2024 Nov 26;14(12):1504. doi: 10.3390/biom14121504.
6
Inflammation-Associated Stem Cells in Gastrointestinal Cancers: Their Utility as Prognostic Biomarkers and Therapeutic Targets.胃肠道癌症中与炎症相关的干细胞:其作为预后生物标志物和治疗靶点的效用
Cancers (Basel). 2024 Sep 12;16(18):3134. doi: 10.3390/cancers16183134.
7
Targeting SNAI1-Mediated Colorectal Cancer Chemoresistance and Stemness by Sphingosine Kinase 2 Inhibition.通过抑制鞘氨醇激酶2靶向SNAI1介导的结直肠癌化疗耐药性和干性
World J Oncol. 2024 Oct;15(5):744-757. doi: 10.14740/wjon1890. Epub 2024 Sep 16.
8
Polymeric Micelles in Colorectal Cancer Therapy: A Comprehensive Review of Nano-drug Delivery Strategies, Copolymer Types, Physicochemical Characteristics, and Therapeutic Applications.聚合物胶束在结直肠癌治疗中的应用:纳米药物递送策略、共聚物类型、物理化学特性及治疗应用的综合综述
Curr Med Chem. 2024 Aug 1. doi: 10.2174/0109298673306752240726104241.
9
Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA).利用小干扰RNA(siRNA)靶向肝癌干细胞(CSCs)及相关耐药性
Cell Biochem Biophys. 2024 Dec;82(4):3031-3051. doi: 10.1007/s12013-024-01423-5. Epub 2024 Jul 26.
10
Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression and by blocking the NF-kB p65/PD-L1 pathway.白术内酯II与干扰素-γ联合使用可通过阻断NF-κB p65/PD-L1信号通路协同改善结直肠癌进展。
J Cancer. 2024 Jun 11;15(13):4328-4344. doi: 10.7150/jca.96647. eCollection 2024.
Signal Transduct Target Ther. 2020 Mar 20;5(1):22. doi: 10.1038/s41392-020-0116-z.
4
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
5
A pre-existing population of ZEB2 quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer.在结直肠癌中,具有干性和间充质特征的 ZEB2 静止细胞的预先存在的群体决定了化疗耐药性。
J Exp Clin Cancer Res. 2020 Jan 8;39(1):2. doi: 10.1186/s13046-019-1505-4.
6
WEE1 inhibitor, AZD1775, overcomes trastuzumab resistance by targeting cancer stem-like properties in HER2-positive breast cancer.WEE1 抑制剂 AZD1775 通过靶向 HER2 阳性乳腺癌中的癌症干细胞样特性来克服曲妥珠单抗耐药性。
Cancer Lett. 2020 Mar 1;472:119-131. doi: 10.1016/j.canlet.2019.12.023. Epub 2019 Dec 19.
7
Role of CD44 in breast cancer.CD44在乳腺癌中的作用。
Breast Dis. 2020;39(1):1-13. doi: 10.3233/BD-190409.
8
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.5-氟尿嘧啶和其他氟代嘧啶类药物在结直肠癌中的应用:过去、现在和未来。
Pharmacol Ther. 2020 Feb;206:107447. doi: 10.1016/j.pharmthera.2019.107447. Epub 2019 Nov 19.
9
A view on drug resistance in cancer.癌症耐药性的观点。
Nature. 2019 Nov;575(7782):299-309. doi: 10.1038/s41586-019-1730-1. Epub 2019 Nov 13.
10
Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance.Wnt-β-catenin 信号通路:癌症多药耐药性的阿喀琉斯之踵。
Curr Pharm Des. 2019;25(39):4192-4207. doi: 10.2174/1381612825666191112142943.